132 related articles for article (PubMed ID: 7613518)
21. Down-regulation of TRRAP-dependent hTERT and TRRAP-independent CAD activation by Myc/Max contributes to the differentiation of HL60 cells after exposure to DMSO.
Jiang G; Bi K; Tang T; Wang J; Zhang Y; Zhang W; Ren H; Bai H; Wang Y
Int Immunopharmacol; 2006 Jul; 6(7):1204-13. PubMed ID: 16714225
[TBL] [Abstract][Full Text] [Related]
22. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
23. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19.
Edelhoff S; Ayer DE; Zervos AS; Steingrímsson E; Jenkins NA; Copeland NG; Eisenman RN; Brent R; Disteche CM
Oncogene; 1994 Feb; 9(2):665-8. PubMed ID: 8290278
[TBL] [Abstract][Full Text] [Related]
24. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
25. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
[TBL] [Abstract][Full Text] [Related]
26. c-Myc inactivation by mutant Max alters growth and morphology of NCI-H-630 colon cancer cells.
Borrè A; Cultraro CM; Segal S
J Cell Physiol; 1996 Oct; 169(1):200-8. PubMed ID: 8841436
[TBL] [Abstract][Full Text] [Related]
27. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S
Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748
[TBL] [Abstract][Full Text] [Related]
28. Repression by the Mad(Mxi1)-Sin3 complex.
Schreiber-Agus N; DePinho RA
Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
[TBL] [Abstract][Full Text] [Related]
29. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
[TBL] [Abstract][Full Text] [Related]
30. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
Koskinen PJ; Ayer DE; Eisenman RN
Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
[TBL] [Abstract][Full Text] [Related]
31. Gene-target recognition among members of the myc superfamily and implications for oncogenesis.
O'Hagan RC; Schreiber-Agus N; Chen K; David G; Engelman JA; Schwab R; Alland L; Thomson C; Ronning DR; Sacchettini JC; Meltzer P; DePinho RA
Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054
[TBL] [Abstract][Full Text] [Related]
32. Specific c-myc and max regulation in epithelial cells.
Martel C; Lallemand D; Crémisi C
Oncogene; 1995 Jun; 10(11):2195-205. PubMed ID: 7784064
[TBL] [Abstract][Full Text] [Related]
33. Identification of Mad as a repressor of the human telomerase (hTERT) gene.
Oh S; Song YH; Yim J; Kim TK
Oncogene; 2000 Mar; 19(11):1485-90. PubMed ID: 10723141
[TBL] [Abstract][Full Text] [Related]
34. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
Ayer DE; Eisenman RN
Genes Dev; 1993 Nov; 7(11):2110-9. PubMed ID: 8224841
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of Mad transcription factor inhibits proliferation of cultured human hepatocellular carcinoma cells along with tumor formation in immunodeficient animals.
Gagandeep S; Ott M; Nisen PD; DePinho RA; Gupta S
J Gene Med; 2000; 2(2):117-27. PubMed ID: 10809145
[TBL] [Abstract][Full Text] [Related]
36. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
[TBL] [Abstract][Full Text] [Related]
38. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3.
Ayer DE; Lawrence QA; Eisenman RN
Cell; 1995 Mar; 80(5):767-76. PubMed ID: 7889570
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of Myc/Max/Mad expression during luteinization of primate granulosa cells in vitro: association with periovulatory proliferation.
Chaffin CL; Brogan RS; Stouffer RL; VandeVoort CA
Endocrinology; 2003 Apr; 144(4):1249-56. PubMed ID: 12639907
[TBL] [Abstract][Full Text] [Related]
40. MAD genes attack cancer cells.
Nature; 1995 Jul; 376(6535):96. PubMed ID: 7596444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
